Taking stock of where we are in the Coronavirus pandemic.
 

COVID-19: Closer to the end than the beginning?

Medical News Today is taking stock of where we are in the coronavirus pandemic and looking back at the developments of the past month. Are we closer to the end than the beginning?

There are encouraging signs from research into prevention and treatments. This week, we reported early trial results for the ‘Oxford vaccine’, ChAdOx1 nCoV-19, that may become available as early as this winter. The UK government has placed an order for 100 million doses.

There is also evidence that zinc has a role to play in prevention, and existing drugs that reduce mortality have been added to the treatment stack.

Meanwhile, while we’re all in this together, sadly not all of us are equally affected. Our investigations into health inequities continued throughout July with reports on COVID-19-related discrimination and a study on the disproportionate effects of race and ethnicity on the severity of COVID-19.

We’re also looking ahead, in this Special Feature on how life might look ‘post lockdown’, with contributions from people around the world.

So, while we’re not through the crisis yet, and authorities as far apart as the WHO and President Trump say that it's likely to get worse before it gets better, there are signs of hope: new vaccines are showing promising early results and old ones are being repurposed to positive effects. Could this month mark the beginning of the end for the pandemic? Let’s venture a cautious yes.

Robin Hough ⁠Editor-in-Chief, Medical News Today

Stay informed with the latest developments in the current COVID-19 pandemic and our dedicated COVID-19 daily newsletter.

Editor’s Picks

MMR vaccine could prevent worst symptoms of COVID-19
New research finds that the MMR, the common vaccine against measles, mumps, and rubella, can prevent the most severe symptoms in COVID-19.
READ ON Read on
Synthetic antibody could prevent and treat COVID-19
Using mouse models, researchers from Tulane University identified a synthetic antibody that may be able to prevent and treat infections with SARS-CoV-2.
READ ON Read on
What was the impact of Sweden’s soft approach to lockdown?
A recent study explores how Sweden's relatively soft COVID-19 lockdown measures have impacted per capita death rates, compared with neighboring countries.
READ ON Read on
COVID-19 and face masks: To wear or not to wear?
Many countries recommend face masks in public to curb the COVID-19 pandemic. We look at common reasons why some people do not wear them.
READ ON Read on
35% of excess deaths from pandemic not caused by COVID-19
A recent study finds that in the United States, around 35% of excess deaths during the early phase of the pandemic were not directly caused by COVID-19.
READ ON Read on
View in browser
Did a friend send you this email? Sign up here.
Privacy Policy  |   Unsubscribe
© 2020 Healthline Media UK Limited, a Red Ventures company
660 3rd Street, San Francisco, CA 94107